Some email communications may be filtered to your Spam or Junk folder, even if you have subscribed to them. Please mark policy@aaci-cancer.ccsend.com as a Safe Sender to ensure that AACI policy emails are delivered to your inbox. 

Summer 2026

AACI Public Policy Roundup
 

About This Newsletter

 
AACI stacked 2-color logo

The Association of American Cancer Institutes represents over 100 premier academic and freestanding cancer centers in the United States and Canada.

Amplifying Your Impact in Washington


The AACI Public Policy Roundup is a seasonal snapshot of AACI's ongoing public policy and advocacy activities.


This quarterly publication will take the place of AACI Commentary four times a year to provide a more focused look at the policy issues shaping the oncology field.

 

Summer 2026 Policy Priorities


As Congress heads into the August recess and attention increasingly turns toward the 2026 midterm elections, several major funding and regulatory issues remain front and center for academic cancer centers.


Last month, AACI submitted institutional comments in response to the White House Office of Management and Budget (OMB) proposed rule, Regulation for Federal Financial Assistance, to express concerns about provisions that could impact merit review and grant delivery. The Senate recently passed a continuing resolution, which would fund the government through December 11 and delay implementation of the proposal. While this is an encouraging development, differences with the House-passed measure are awaiting resolution.


AACI is closely monitoring the 340B Drug Pricing Program and how potential updates may impact cancer centers. Centers for Medicare & Medicaid Services proposed significant changes to 340B reimbursement through the CY 2027 Hospital Outpatient Prospective Payment System rule, while the Health Resources and Services Administration is proceeding with a revised 340B rebate pilot. Meanwhile, a bipartisan group of senators recently introduced the SUSTAIN 340B Act, reflecting continued congressional interest in the future of the program.


While lawmakers work toward final funding levels for the National Institutes of Health (NIH) and National Cancer Institute (NCI), AACI continues to advocate for robust, sustained investment in biomedical research and amplify the collective voice of academic cancer centers in Washington.

 

Advocacy Highlights

 

FEDERAL POLICY

AACI Comments on NIH Grant Cap Proposal

AACI submitted a comment letter on Monday, August 3 to NIH leadership in response to its request for information on capping the number of simultaneous research project grants per principal investigator. Read the Letter

AACI Comments on Proposed Changes to Federal Financial Assistance

On Wednesday, July 8, AACI submitted formal comments opposing proposed changes to the OMB's Uniform Guidance that could significantly affect the NIH, NCI, and other agencies that support cancer research. Read More

OVAC Congressional Briefing Highlights Federal Investment in Cancer Research

Drs. Anthony Letai and Barry P. Sleckman

On Tuesday, June 23, AACI participated in a bipartisan congressional briefing on Capitol Hill, hosted by One Voice Against Cancer (OVAC). The briefing highlighted the impact of federally funded cancer research and the critical role of the NCI in advancing progress against the disease. Read More

AACI Executive Director Speaks at KO Cancer Act Press Conference

Jennifer W. Pegher at K.O. Cancer Act press conference

On Tuesday, May 19, AACI Executive Director Jennifer W. Pegher joined Representatives Brian Fitzpatrick (R-PA) and Debbie Dingell (D-MI), sponsors of the Knock Out (KO) Cancer Act (H.R. 3873), at a press conference to generate support for the bill. Read More

Cancer Research Advocates Unite at 2026 AACI/AACR Hill Day

2026 AACI/AACR Hill Day photo collage

On Thursday, May 14, AACI co-hosted its annual joint Hill Day with the American Association for Cancer Research (AACR). Attendees reflected on decades of progress against cancer while embracing the future of cancer research and the lifesaving discoveries it holds. Read More

STATE POLICY

 
Public Policy Resource Library horizontal logo

The AACI Public Policy Resource Library tracks state legislation and policy developments affecting cancer prevention, treatment, research, and access to care. 

 

Maine Removes Cost Barriers to Prostate Cancer Screenings

Maine enacted legislation removing patient cost-sharing requirements for prostate cancer screenings, expanding access to preventive care. Read More

Alabama Invests in Rural Cancer Care

Alabama appropriated more than $8 million to support a statewide cancer digital regionalization initiative as part of a broader rural health transformation effort. Read More

Oklahoma Expands Coverage for Cancer Imaging and Genetic Testing

New legislation requires insurance coverage for evidence-based cancer imaging and genetic testing services. Read More

Hawai‘i Funds Colorectal Cancer Health Equity Initiative

Hawai‘i approved $1.8 million to support programs addressing colorectal cancer disparities across the state. Read More

 

Resources

 

FEDERAL LEGISLATION UPDATES

 

In addition to following state-level policy developments, AACI monitors the status of cancer-related federal legislation, from introduction to enactment, through its Federal Legislation Tracker.

 

Cancer Drug Parity Act

The Cancer Drug Parity Act was reintroduced in the Senate on July 15, 2026.

Clinical Trial Modernization Act

AACI joined a letter with nearly 200 patient, public health, and health care professional groups to strongly endorse the Clinical Trial Modernization Act accompanied by a press release.

Women and Lung Cancer Research and Preventive Services Act

The Women and Lung Cancer Research and Preventive Services Act passed in the Senate with an amendment by Unanimous Consent.

 

IN BRIEF: CANCER CENTER UPDATE CALL GUESTS

Max Cohen

Max Cohen

Punchbowl News


July 2026


Key takeaway: Congress is expected to focus on must-pass legislation through the election, with limited opportunities for major health care bills before November.

Dr. Carrie Wolinetz

Carrie Wolinetz, PhD

Lewis-Burke Associates


June 2026


Key takeaway: The proposed OMB grant rule could fundamentally reshape federal grantmaking, making targeted, evidence-based comments especially important.

Jason Kleinman

Jason Kleinman

American Hospital Association


May 2026


Key takeaway: Site-neutral payment proposals remain a persistent threat, and hospitals must continue educating policymakers about their impact on patient access.

Upcoming Events

 

2026 Rally for Medical Research

REGISTER TODAY

Thursday, September 17

Washington, DC

2026 AACI Government Relations Forum

SAVE THE DATE

Monday, October 26, 2:00 pm CT

Chicago, IL


The Government Relations Forum will be held in conjunction with the 2026 AACI/CCAF Annual Meeting, October 25-27, at the Chicago Marriott Downtown Magnificent Mile.

2027 AACI/AACR Hill Day

SAVE THE DATE

Thursday, May 20, 2027

Washington, DC

Meet the Team: Policy & Government Affairs

 
Jaren Love

Jaren Love, MBA, MPPM

Director of Policy & Government Affairs

Omasan Richardson

Omasan Richardson

Policy & Government Affairs Coordinator

 

Copyright 2026 | Association of American Cancer Institutes

322 North Shore Drive

Building 1B, Suite 200, #362

Pittsburgh, PA 15212-5875

FOLLOW US
Bluesky  Facebook  Instagram  LinkedIn  X  YouTube
X Share This Email
LinkedIn Share This Email